Introduction
Endometriosis is an inflammatory disease associated with pelvic pain and infertility that is characterized by lesions of endometrial-like tissue outside of the uterus (Johnson and Hummelshoj, 2013) . The prevalence of endometriosis has been estimated as 176 million women worldwide .
Classification of endometriosis has remained controversial and challenging, due to the many manifestations of the disease, wherein the focus has been on anatomy, histology and disease burden for 'surgical staging' and, more recently, on prognostic value. These efforts have largely struggled to yield a suitable solution to enhance the utility of disease classification in endometriosis-related symptom management, prognosis for response to therapies, recurrence, association with other disorders, quality of life and other elements of key concern to women with endometriosis.
The best-known classification system for endometriosis is the revised American Society for Reproductive Medicine (r-ASRM) classification (1997) . In addition to the r-ASRM classification, emerging systems include the Enzian classification for deep endometriosis (Keckstein et al., 2003; Haas et al., 2013) , the endometriosis fertility index (EFI) (Adamson and Pasta, 2010) , and the American Association of Gynecological Laparoscopists (AAGL) classification (http://www. aagl.org/wp-content/uploads/2013/03/NewsScope_Oct-Dec_2012.pdf; accessed 1 February 2016; unpublished to date). However, the classification systems in current use continue to attract criticism from women with endometriosis and those providing care for them because of the poor correlation with disease symptoms as well as a lack of predictive prognosis and, to date, unclear pathways of treating pelvic pain and infertility based on its classification. This lack of correlation has led to the pertinent question: why classify endometriosis? We propose that if classification of endometriosis ultimately has benefit for women suffering from the disease with informed counselling by health care providers, then it can form the bridge between diagnosing a woman with endometriosis and enabling her the most successful treatment possible based on her symptoms and the physical disease present. Adamson (2011) highlighted the criteria for a good classification system, and one that should therefore benefit women with endometriosis. It should be simple (for doctors to explain and for women to understand) and easy to perform; allow a simple description of the disease; correlate well with problems experienced by women, especially pain and infertility; give prognostic information; predict response to treatment for (i) pain and (ii) infertility and (iii) recurrence of symptoms after treatment (Adamson, 2011) . Additional good qualities of the ideal classification system are that it should be empirically and scientifically based; comprehensive for all cases; use unambiguously defined terms; have a simple translation from anatomic lesion to verbal description; reflect the progression of the disease (with scientifically derived, and not arbitrary, cut-off points that are clinically meaningful); finally, it should have general consensus (Adamson, 2011) .
The World Endometriosis Society (WES) established a process to bring together representatives of national and international, medical and non-medical societies, patient organizations and pharmaceutical companies with an interest in endometriosis, aiming to derive a consensus on the classification of endometriosis from a global perspective in which the views of health care providers, researchers and women with endometriosis were represented. The aim was to attain a consensus around classification to enable a pathway that assists the healthcare team and women who present with symptoms of possible endometriosis in securing effective treatment. This document contains a summary of the WES consensus on the classification of endometriosis: a full-length article can be found online at http://humrep. oxfordjournals.org/.
Materials and Methods
We developed a consensus process supported by a specific methodology, detailed in the full length article at http://humrep.oxfordjournals.org/), similar to that used for our previous consensus statement on the management of endometriosis (Johnson and Hummelshoj, 2013) .
Results
The evidence tables (Table V in the full-length article at http:// humrep.oxfordjournals.org/) provide the evidence that was considered to reach the consensus statements. The consensus statements, categorised as either 'strong' or 'weak', are summarised in Table I , along with the degree of consensus that applied to each statement. More detailed information, specifically relating to caveats to the evidence statements, is available in the full-length article at http:// humrep.oxfordjournals.org/.
Discussion
We have developed the first international consensus statement on the classification of endometriosis through rigorous methodology. We recommend a classification toolbox that may be used by all surgeons in each case of surgery undertaken for women with endometriosis, from which surgeons may select the appropriate components and ensure this is documented in the patient medical/surgical record (Fig. 1) .
No single classification system adequately classifies endometriosis. It has been demonstrated already that the available systems have little prognostic value, with the exception of the EFI, which probably works because it includes important clinical variables that have an effect on the likelihood of pregnancy independent of the presence of endometriosis. Although it has been raised that this may respect endometriotic lesions insufficiently, it is clear that classification systems relying solely on surgical findings have inadequate predictive value for outcomes important to women. Even for a description of the disease, in terms of correlation with severity of symptoms and infertility and their impact on women, the existing classification systems have shortcomings. However, a recent proposal for endometriosis classification from Koninckx et al. (2011) adding adenomyosis, peritoneal pocket lesions, and subtle endometriosis to the three more traditionally recognised lesion phenotypes (typical (peritoneal), cystic and deep endometriosis) and placing emphasis on the size of lesions is awaiting further appraisal and validation. While not all classification systems are well understood, those that have a level of acceptance are r-ASRM (whose main advantage is its longevity, universal familiarity and its embedding in many other classification systems), Enzian (for deep endometriosis) and the EFI (owing to its value in predicting fertility and the external validation of that) and thus these systems all have some merit. The inextricable interlinking of r-ASRM with newer classification systems (Enzian and EFI) means that a classification that has attracted no small measure of criticism appears to have been immortally enshrined. Although the AAGL classification has the investment of the opinions of a quorum of surgical opinion leaders involved in its development it is yet to be fully validated and published. The absence of consensus around the utility of the AAGL system reflects this.
There is no general consensus on the most appropriate methodology for consensus statements, particularly for disease classifications. Therefore we adopted a modified version (Table IV in the full length article at http://humrep.oxfordjournals.org/) of the GRADE system of grading the quality of evidence (Guyatt et al., 2008) , now recognised as the most relevant method of grading evidence and recommendations in guidelines. We adapted this to our consensus process, which we based on previous consensus documents, using a system promoted by the ACCEPT Group that is gaining wider acceptance (Kroon et al, 2011; Koch et al., 2012; Johnson and Hummelshoj, 2013; Boothroyd et al., 2015) . It must also be acknowledged that a consensus statement from international experts would likely be different with a different group of experts, although it is hoped that our broad sample of participants in this consortium was representative of the spectrum of viewpoints of all the members of all the organizations and societies representing stakeholders in endometriosis research, clinical care and advocacy.
An obvious finding in the quest for a consensus statement is that absolute unanimity from a range of experts regarding any statement is difficult to attain. However, our methodology sequence, with an additional step to refine our consensus statements after our consensus meeting, then a second survey step to refine further selected statements in the case of statements for which it was judged to be required, was associated with higher degrees of consensus than with our previous consensus statement on the management of endometriosis (Johnson and Hummelshoj, 2013) . From our survey that followed the consensus meeting, ten of the 28 statements were graded unanimous (α) consensus, even though none reached 100% agreement without expression of a caveat about either the statement or the strength of the statement; four of our 28 consensus statements were associated with a 0% disagreement rate from the survey respondents (consensus statements 2, 3, 6 and 13). In the case of only two statements were we unable to achieve a majority consensus (statements 4 and 23). It must also be stressed that, by its very definition, and the finding that there was 100% agreement without caveat for none of the consensus statements, these consensus statements will not be expected to completely reflect the views of all of the individual participants and their organizations.
The strengths of this consensus document are its established methodology, the broad international representation including individuals from 19 countries across medical, surgical, and fertility organizationsand included a viewpoint from the women themselves via participation of eight endometriosis organizations. There are potential weaknesses in a consensus process such as this. Few of our statements are based on strong research evidence and many statements are based on opinion and termed 'good practice points' (GPPs); however, such statements could still be associated with a strong consensus amongst the group of experts. It is possible that we have overlooked some statements that have relevance, in spite of the methodology and feedback from all participants. It is therefore intended that this consensus will be updated regularly in response to feedback and, hopefully, increasing research evidence in this field. 1) The ideal classification system for endometriosis should be standardized, pragmatic, cost effective and user friendly (for affected women, health care professionals, and researchers) so that it results in achievable strategies that increase access to and attainment of outcomes important to women with endometriosis and promotes standardization of disease phenotypes to optimize research study design (strong GPP).
α 2) Classification of endometriosis should deliver tangible benefits to affected women, including an understanding of the severity of their disease; its likely impact on their fertility, pain symptoms, and consequently their quality of life; the prognosis without intervention; the likely response and quality of life following treatment for pain and/or infertility; the chance of recurrence of symptoms and disease after treatment (strong GPP).
β Definition
Consensus grading
3) Endometriosis should be defined as an inflammatory disease process, characterized by lesions of endometrial-like tissue outside the uterus that is associated with pelvic pain and/or infertility (strong GPP). 10) The r-ASRM classification system is the longest established method of describing operative findings in current use (strong GPP). α
11) The r-ASRM classification system does not describe deep endometriosis adequately (strong GPP). α
12) The r-ASRM classification system has poor correlation with fertility outcomes (weak). β
13) The r-ASRM classification system has very poor correlation with pain symptoms and quality of life (weak). α
14) The r-ASRM classification system gives poor prognostic information (weak). β
15) The r-ASRM classification system has poor predictive accuracy with respect to treatment outcomes (weak). α
16) The reasons not to abandon the r-ASRM classification system are its longevity, widespread clinical use, its prevalence in the literature describing the operative appearance of endometriosis, and its incorporation into other classification systems of potentially greater value (GPP).
γ
Enzian classification of endometriosis Consensus grading
17) If the r-ASRM classification is to be used, the Enzian classification system should be employed when deep endometriosis is also present to give a complete description of the operative findings (GPP). γ
18) Correlation of Enzian with symptoms and infertility is poor (weak). β

19) Enzian has limited prognostic value for the course of symptoms, quality of life and infertility (weak). β
20) The predictive capacity of Enzian to detect a women's likely response to treatment for pain and/or infertility is uncertain (weak). α
Continued Unsurprisingly, our consensus statements reflect the kind of differences that might be expected from the coalescence of an eclectic group of individuals with different perspectives. One of the real values to the participants in such an exercise is the opportunity to recognise a completely new perspective and interpretation of existing evidencethis can be applied in any multidisciplinary setting, where specialists in medical, surgical and fertility treatment join forces, in our case, with women affected by endometriosis. In some instances, the strength of our statements (and in some cases, even the GRADE score) or the content of statements themselves may be surprising. We endeavoured to make strong statements where (i) the classification system would be of value to women with endometriosis and where the evidence was moderate or strong, i.e. derived from a reliable and reproducible source that had been internally and externally validated with methodological rigour or (ii) where the risk or expense of application of a classification strongly justified its non-use in the context of marginal or insufficient evidence or (iii) where there was considerable potential for benefit from a simple, low invasive, low cost classification, to overcome a substantial burden of suffering, even in the face of only weak or absent research evidence (as in the case of our GPPs).
Given that surgery is the pivotal moment at which these classifications can be defined, until better systems become available, in order to derive the most information from the procedure, our recommendation is that all women undergoing surgery should have the r-ASRM classification completed, women with deep endometriosis should additionally have Enzian completed, and women for whom future fertility is a concern should additionally have the EFI completed. Hence the proposed classification toolbox (Fig. 1) , that incorporates the r-ASRM, Enzian (if required) and EFI (if required), is the current recommended classification method, with possible replacement or addition of new classification systems as their utility is proven. So doing will increase the familiarity of surgeons, the multidisciplinary team involved in a woman's management, and, most importantly, the woman herself, with a greater common understanding about the disease, which we view as potentially beneficial for affected women. Perhaps the biggest barrier to the implementation of this approach is whether those undertaking surgery will have the time and willingness to complete these forms. However, we posit that this should not be used as a reason not to undertake this, as women who undergo laparoscopic surgery might be considered to be in a privileged minority compared to all women worldwide who suffer from endometriosis, and our view is that it is the duty of the caring surgeon to the woman with endometriosis to prioritize this. The ability to record-and later share and utilise-this information is one of the most important aspects of a resource that is not only the only universally accepted gold standard method of diagnosis and an effective treatment, but also an invasive intervention for the woman with endometriosis.
.. ......................................................................................................................................................................................... 23) The AAGL classification system might, in the future, be used instead of the rASRM classification system, as a preliminary study suggests it may have better correlation with infertility, level of pain and surgical difficulty (weak).
δ Endometriosis Fertility Index (EFI) Consensus grading
24) The EFI is a simple, robust, and validated clinical tool that predicts fertility outcome for women following surgical staging of endometriosis and may have considerable utility in developing treatment plans for infertile women with endometriosis (strong).
γ Overarching Consensus Statements on Classification of Endometriosis Consensus grading 25) An endometriosis classification system for pain and/or quality of life should be developed using a similar methodology to the EFI in order to combine the factors most predictive of these outcomes (strong GPP) α 26) We recommend standard methods of ascertaining symptoms, undertaking examination, and performing laparoscopic surgery to standardise the way in which classification of endometriosis is defined (strong GPP) α 27) Classification systems should be developed for low resource settings and settings in which surgery is not undertaken (either through unavailability or through the choice of women) that have utility in predicting endometriosis and its extent; its likely impact on fertility, pain symptoms and thus quality of life; the prognosis without intervention; the likely response to treatment for pain and/or infertility; the chance of recurrence of problems after treatment (strong GPP).
γ 28) Until better classification systems are validated, all women with endometriosis undergoing surgery should have a r-ASRM (or possibly, when published, AAGL) score and stage completed, women with deep endometriosis should have an Enzian classification completed, and women for whom fertility is a future concern should have an EFI score completed, and documented in the medical/surgical records (strong GPP) γ GPP = good practice point; α = unanimous or near-unanimous (more than 80% agreed without caveat and fewer than 5% disagreed); β = unanimous with caveat (either more than 80% agreed without caveat but more than 5% disagreed, or, fewer than 5% disagreed but fewer than 80% agreed without caveat); γ = majority (50-80% agreed); δ = no consensus (fewer than 50% agreed with or without caveat). Several important issues have been raised by this consensus process that we have not addressed, or for which we have not attained consensus. These themes may form topics merit-worthy of further research. First, regarding definitions, we did not address 'subtle' endometriosis (Koninckx et al., 2011) , which some consider should be classified separately. Many authorities argue that the concept of microscopic endometriosis as a cause of pain, infertility, or more severe endometriosis has never been proven. Some have called for recognition of 'stage 0' disease, which could mean strongly suspected endometriosis based on combinations of symptoms and examination findings strongly predictive of endometriosis in women who have not undergone surgical diagnosis; visualized but not histologically confirmed endometriosis in the context of pain symptoms; occult or invisible (microscopic) lesions that are confirmed histologically in biopsy Figure 1 Continued samples as endometriosis. 'Subtle' endometriosis (whether defined as this stage 0-or even stage 0 and r-ASRM stage 1) might simply be a natural condition rather than a pathological disease. There is a groundswell of opinion that subtle endometriosis (as well as deep endometriosis) should be classified separately. We did not address in detail what role adenomyosis should have on the classification of endometriosis. We also did not address how recurrence of endometriosis should be defined. Second, we have called for an endometriosis Figure 1 Continued classification system for pain and/or quality of life to be developed using a similar methodology to the EFI in order to combine the factors most predictive of these outcomes. Such a comprehensive classification system should incorporate all types of endometriosis including those features of deep endometriosis found to have prognostic value. Standardization is crucial to the development of such new classification systems. Formerly, there were no guidelines to standardize even the way in which information is obtained when diagnostic laparoscopy is performed. We now have such standardization available and the World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project (WERF EPHect) tools Vitonis et al., 2014) are expected to transform uniquely the surgical and clinical data collection for women with endometriosis. Third, there is an imperative for the development of an 'empirical' classification system for circumstances in which laparoscopic surgery is not undertaken. Some argue that without laparoscopy there can be no diagnosis, thus no classification. However there may be particular utility for a predictive empirical classification system for women with pelvic/abdominal pain and/or infertility, when other causes have been ruled out. Finally, the possibility that molecular and genetic diagnostics may assist in staging endometriosis, as we have seen in many other diseases including breast cancer, will be an important theme of research over the coming decade. Molecular markers that allow directed treatments based on prognosis and response to treatment have the potential to be directed to women who will benefit most through classifications based on prognosis and response to treatment. Collaborative data collection in a manner described in the WERF EPHect papers highlighting the need for harmonisation of the endometriosis phenome (i.e. the set of all phenotypes expressed), data collection, and specimen handling Vitonis et al., 2014; Rahmioglu et al., 2014; Fassbender et al., 2014) is the key to unlock this considerable potential.
Conclusion
This paper is the outcome of the first attempt to bring a global collaborative consensus to the classification of endometriosis, reflecting the best scientific evidence available and keeping uppermost the goal of improving quality of life for women with endometriosis. Our recommendation is that, until better classification systems have been developed, surgeons should use a toolbox for surgical classification of endometriosis (that includes the r-ASRM system and, where appropriate, the Enzian and EFI staging systems) to maximise the information available to women following their surgery.
